Completed PHASE3 INTERVENTIONAL 2-arm NCT00330902

Randomized Trial of Two Antimalarial Treatments for Clearing Low Density P.Falciparum Parasitaemia in Sudan

Randomized Trial of Sulfadoxine-Pyrimethamine Plus Artesunate (SP+AS) Versus SP+AS Plus Primaquine for Clearance of Low Density P. Falciparum Infection in Eastern Sudan

Sponsor: London School of Hygiene and Tropical Medicine

Conditions Plasmodium Infections

Interventions primaquine (PQ) plus SP+AS sulfadoxine-pyrimethamine (SP) plus artesunate (AS)

Updated 5 times since 2017 Last updated: Oct 30, 2007 Started: Jan 31, 2004 Completion: Nov 30, 2004

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00330902, this PHASE3 trial focuses on Plasmodium Infections and remains completed. Sponsored by London School of Hygiene and Tropical Medicine, it has been updated 5 times since 2004, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Jan 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

London School of Hygiene and Tropical Medicine
Tropical Medicine Research Institute
World Health Organization

Data source: London School of Hygiene and Tropical Medicine

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Khartoum, Sudan